Scientists test 'Re-Educated' immune cells to halt debilitating MS
NCT ID NCT07020715
Summary
This early-stage trial is testing a personalized cell therapy for people with progressive multiple sclerosis (MS). Doctors take a patient's own immune cells, modify them in a lab to potentially calm the immune attack on the brain and spinal cord, and then inject them back. The main goal is to see if this approach is safe and can slow the worsening of disability in 14 participants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Germans Trias i Pujol Hospital (HUGTiP)
Badalona, 08916, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Email: •••••@•••••
-
Universitair Ziekenhuis Antwerpen (UZA)
Edegem, 2650, Belgium
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.